{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T16:47:23Z","timestamp":1758818843755},"reference-count":90,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Primary Care: Clinics in Office Practice"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/j.pop.2010.05.001","type":"journal-article","created":{"date-parts":[[2010,8,11]],"date-time":"2010-08-11T08:50:18Z","timestamp":1281516618000},"page":"441-459","source":"Crossref","is-referenced-by-count":11,"title":["Prostate-specific Antigen Testing and Prostate Cancer Screening"],"prefix":"10.1016","volume":"37","author":[{"given":"Bob","family":"Djavan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Eckersberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Finkelstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Sadri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samir S.","family":"Taneja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herbert","family":"Lepor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pop.2010.05.001_bib1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3322\/canjclin.51.1.15","article-title":"Cancer statistics 2001","volume":"51","author":"Greenlee","year":"2001","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.pop.2010.05.001_bib2","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1161\/01.CIR.0000133321.00456.00","article-title":"Preventing cancer, cardiovascular disease, and diabetes. A common agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association","volume":"109","author":"Eyre","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.pop.2010.05.001_bib3","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/(SICI)1097-0215(20000101)85:1<60::AID-IJC11>3.0.CO;2-B","article-title":"International trends and patterns of prostate cancer incidence and mortality","volume":"85","author":"Hsing","year":"2000","journal-title":"Int J Cancer"},{"key":"10.1016\/j.pop.2010.05.001_bib4","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0094-0143(02)00002-2","article-title":"Prostate cancer trends in the era of prostate specific antigen: an update of incidence, mortality, and clinical factors from the SEER database","volume":"29","author":"Stephenson","year":"2002","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.pop.2010.05.001_bib5","author":"Horner"},{"key":"10.1016\/j.pop.2010.05.001_bib6","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/0140-6736(92)90927-U","article-title":"5-Alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males","volume":"339","author":"Ross","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.pop.2010.05.001_bib7","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1002\/1097-0142(19950401)75:7+<1778::AID-CNCR2820751605>3.0.CO;2-J","article-title":"Does the racial-ethnic variation in prostate cancer risk have a hormonal basis?","volume":"75","author":"Ross","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.pop.2010.05.001_bib8","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S0140-6736(98)11282-5","article-title":"Association of mis-sense substitution in SRD5A2 gene with prostate cancer in African American and Hispanic men in Los Angeles","volume":"354","author":"Makridakis","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.pop.2010.05.001_bib9","doi-asserted-by":"crossref","first-page":"4400","DOI":"10.1210\/jc.81.12.4400","article-title":"Androgen receptor CAG repeat lengths in prostate cancer: correlation with age of onset","volume":"81","author":"Hardy","year":"1996","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.pop.2010.05.001_bib10","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/jnci\/86.4.252","article-title":"Do diet and androgen alter prostate cancer risk via a common etiologic pathway?","volume":"86","author":"Ross","year":"1994","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.pop.2010.05.001_bib11","first-page":"901","article-title":"Association between CYP3A4 genetic variant and clinical presentation in African American prostate cancer patients","volume":"8","author":"Paris","year":"1998","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.pop.2010.05.001_bib12","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1093\/jnci\/91.5.414","article-title":"Dietary fat and prostate cancer: current status","volume":"91","author":"Kolonel","year":"1999","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.pop.2010.05.001_bib13","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1159\/000019912","article-title":"Diet and its preventive role in prostatic disease","volume":"35","author":"Denis","year":"1999","journal-title":"Eur Urol"},{"key":"10.1016\/j.pop.2010.05.001_bib14","first-page":"83","article-title":"Rising incidence of prostate cancer in Shanghai","volume":"7","author":"Hsing","year":"1998","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.pop.2010.05.001_bib15","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/sj.ijo.0800603","article-title":"Changes in diet and physical activity affect the body mass index of Chinese adults","volume":"22","author":"Paeratakul","year":"1998","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"13","key":"10.1016\/j.pop.2010.05.001_bib16","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.eursup.2009.11.003","article-title":"Complex mechanisms in prostatic inflammatory response","volume":"8","author":"Djavan","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.pop.2010.05.001_bib17","first-page":"51","article-title":"Biomarkers for early prostate cancer detection","volume":"60","author":"Margreiter","year":"2008","journal-title":"Minerva Urol Nefrol"},{"issue":"1","key":"10.1016\/j.pop.2010.05.001_bib18","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0014-5793(89)81253-0","article-title":"The prostate-specific antigen gene and the human glandular kallikrein-1 gene are tandemly located on chromosome 19","volume":"247","author":"Riegman","year":"1989","journal-title":"FEBS Lett"},{"issue":"Suppl 2","key":"10.1016\/j.pop.2010.05.001_bib19","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000049878","article-title":"Rising PSA with negative biopsy","volume":"40","author":"Boccon-Gibod","year":"2001","journal-title":"Eur Urol"},{"key":"10.1016\/j.pop.2010.05.001_bib20","first-page":"1476","article-title":"Complexed prostate specific antigen provides significant enhancement of specificity compared with total prostate specific antigen for detecting prostate cancer","volume":"163","author":"Brawer","year":"2000","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.pop.2010.05.001_bib21","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0090-4295(98)00575-5","article-title":"Prostate cancer histologic trends in the Metropolitan Detroit area, 1982 to 1996","volume":"53","author":"Schwartz","year":"1999","journal-title":"Urology"},{"key":"10.1016\/j.pop.2010.05.001_bib22","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1001\/jama.279.19.1542","article-title":"Use of percentage of free prostate specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial","volume":"279","author":"Catalona","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.pop.2010.05.001_bib23","first-page":"910","article-title":"Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results","volume":"172","author":"Roehl","year":"2004","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.pop.2010.05.001_bib24","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0090-4295(01)01441-8","article-title":"Contemporary update of prostate cancer staging nomograms (Partin tables) for the new millennium","volume":"58","author":"Partin","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.pop.2010.05.001_bib25","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1093\/jnci\/90.10.766","article-title":"A\u00a0preoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer","volume":"90","author":"Kattan","year":"1998","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.pop.2010.05.001_bib26","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1200\/JCO.2000.18.19.3352","article-title":"Pretreatment nomogram for predicting the outcome of three-dimensional conformal radiotherapy in prostate cancer","volume":"18","author":"Kattan","year":"2000","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pop.2010.05.001_bib27","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0090-4295(01)01233-X","article-title":"Pretreatment nomogram for predicting freedom from recurrence after permanent prostate brachytherapy in prostate cancer","volume":"58","author":"Kattan","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.pop.2010.05.001_bib28","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1056\/NEJM199104253241702","article-title":"Measurement of prostate specific antigen in serum as a screening test for prostate cancer","volume":"324","author":"Catalona","year":"1991","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pop.2010.05.001_bib29","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1097\/00007611-199407000-00009","article-title":"Prostate specific antigen and digital rectal examination in screening for prostate cancer: a community based study","volume":"87","author":"Bretton","year":"1994","journal-title":"South Med J"},{"key":"10.1016\/j.pop.2010.05.001_bib30","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1001\/jama.270.8.948","article-title":"Detection of organ confined prostate cancer is increased through prostate specific antigen based screening","volume":"270","author":"Catalona","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.pop.2010.05.001_bib31","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1001\/jama.277.18.1452","article-title":"Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng\/ml and benign prostate examination. Enhancement of specificity with free PSA measurements","volume":"277","author":"Catalona","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.pop.2010.05.001_bib32","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0090-4295(99)00185-5","article-title":"Use of percentage of free prostate specific antigen to identify men at high risk of prostate cancer when PSA levels are 2.51 to 4 ng\/ml and digital rectal examination is not suspicious for prostate cancer: an alternative model","volume":"54","author":"Catalona","year":"1999","journal-title":"Urology"},{"key":"10.1016\/j.pop.2010.05.001_bib33","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0090-4295(99)00153-3","article-title":"PSA, PSA density, PSA density of transitional zone, free\/total PSA ratio, and PSA velocity for early detection of prostate cancer in men with serum PSA 2.5 to 4.0 ng\/ml","volume":"54","author":"Djavan","year":"1999","journal-title":"Urology"},{"key":"10.1016\/j.pop.2010.05.001_bib34","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0090-4295(00)00830-X","article-title":"Performance of a neural network in detecting prostate cancer in the prostate-specific antigen reflex range of 2.5 to 4.0 ng\/ml","volume":"56","author":"Babaian","year":"2000","journal-title":"Urology"},{"issue":"5","key":"10.1016\/j.pop.2010.05.001_bib35","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/modpathol.3800583","article-title":"Prostate cancer detected by uPM3: radical prostatectomy findings","volume":"19","author":"Bostwick","year":"2006","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pop.2010.05.001_bib36","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S1078-1439(01)00145-4","article-title":"Introduction to the Department of Defense Center for Prostate Disease Research Multicenter National Prostate Cancer Database and analysis in the PSA era","author":"Sun","year":"2001","journal-title":"Urol Oncol"},{"key":"10.1016\/j.pop.2010.05.001_bib37","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/BF01300179","article-title":"Population-based prostate cancer trends in the United States: patterns of change in the era of prostate specific antigen","volume":"15","author":"Stephenson","year":"1997","journal-title":"World J Urol"},{"key":"10.1016\/j.pop.2010.05.001_bib38","first-page":"411","article-title":"Prostate specific antigen density of the transitional zone for early detection of prostate cancer","volume":"160","author":"Djavan","year":"1998","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.pop.2010.05.001_bib39","first-page":"1144","article-title":"Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1051 patients","volume":"163","author":"Djavan","year":"2000","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.pop.2010.05.001_bib40","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1056\/NEJM198710083171501","article-title":"Prostate specific antigen as a serum marker for adenocarcinoma of the prostate","volume":"317","author":"Stamey","year":"1987","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pop.2010.05.001_bib41","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/jcla.1860040212","article-title":"Prostate specific antigen and prostate gland volume: correlation and clinical application","volume":"4","author":"Babaian","year":"1990","journal-title":"J\u00a0Clin Lab Anal"},{"key":"10.1016\/j.pop.2010.05.001_bib42","first-page":"817","article-title":"The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen","volume":"147","author":"Benson","year":"1992","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.pop.2010.05.001_bib43","first-page":"502","volume":"158","author":"Morote","year":"1997","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.pop.2010.05.001_bib44","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/jjco\/29.12.617","article-title":"Determination of reference values for total PSA, F\/T and PSAD according to prostatic volume in Japanese prostate cancer patients with slightly elevated serum PSA levels","volume":"29","author":"Kuriyama","year":"1999","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.pop.2010.05.001_bib45","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1002\/(SICI)1097-0142(19971101)80:9<1818::AID-CNCR21>3.0.CO;2-7","article-title":"Prostate cancer screening in the county of Tyrol, Austria: experience and results","volume":"80","author":"Reissigl","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.pop.2010.05.001_bib46","first-page":"444","article-title":"Age specific prostate specific antigen reference ranges: population specific","volume":"159","author":"Borer","year":"1998","journal-title":"J\u00a0Urol"},{"issue":"6","key":"10.1016\/j.pop.2010.05.001_bib47","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1002\/1097-0142(19930315)71:6<2031::AID-CNCR2820710618>3.0.CO;2-Q","article-title":"Observations on the doubling time of prostate cancer. The use of serial prostate-specific antigen in patients with untreated disease as a measure of increasing cancer volume","volume":"71","author":"Schmid","year":"1993","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.pop.2010.05.001_bib48","first-page":"3323","article-title":"Estimation of prostatic growth using serial prostate-specific antigen measurements in men with and without prostate disease","volume":"52","author":"Carter","year":"1992","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.pop.2010.05.001_bib49","first-page":"2179","article-title":"Biological variation of total, free and percent free serum prostate specific antigen levels in screening volunteers","volume":"157","author":"Ornstein","year":"1997","journal-title":"J\u00a0Urol"},{"issue":"2","key":"10.1016\/j.pop.2010.05.001_bib50","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/sj.pcan.4500212","article-title":"Day to day changes in free and total PSA: significance of biological variation","volume":"1","author":"Nixon","year":"1997","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"Suppl","key":"10.1016\/j.pop.2010.05.001_bib51","first-page":"239A","article-title":"The significance of short term PSA change in men undergoing ultrasound guided prostate biopsy","volume":"264","author":"Porter","year":"1994","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.pop.2010.05.001_bib52","first-page":"420","article-title":"Comparison of three investigational assays for the free form of prostate specific antigen","volume":"160","author":"Nixon","year":"1998","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.pop.2010.05.001_bib53","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0090-4295(98)00241-6","article-title":"Measurement of complexed PSA improves the specificity for early detection of prostate cancer","volume":"52","author":"Brawer","year":"1998","journal-title":"Urology"},{"key":"10.1016\/j.pop.2010.05.001_bib54","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/S0090-4295(99)00589-0","article-title":"Comparison of two investigational assays for the complexed prostate specific antigen in total prostate specific antigen between 4.0 and 10.0 ng\/ml","volume":"55","author":"Okegawa","year":"2000","journal-title":"Urology"},{"key":"10.1016\/j.pop.2010.05.001_bib55","first-page":"49","article-title":"A\u00a0prospective study to evaluate the role of complexed prostate specific antigen and free\/total prostate specific antigen ratio for the diagnosis of prostate cancer","volume":"165","author":"Mitchell","year":"2001","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.pop.2010.05.001_bib56","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/S0090-4295(01)00953-0","article-title":"Contemporary use of complexed PSA and calculated per cent free PSA for early detection of prostate cancer: impact of changing demographics","volume":"57","author":"Miller","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.pop.2010.05.001_bib57","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0090-4295(02)01896-4","volume":"60","author":"Djavan","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.pop.2010.05.001_bib58","first-page":"2017","article-title":"Comparative analysis of complexed prostate specific antigen, free prostate specific antigen, and their ratio in detecting prostate cancer","volume":"167","author":"Okihara","year":"2002","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.pop.2010.05.001_bib59","first-page":"119","article-title":"Examination of the 3 molecular forms of serum prostate specific antigen for distinguishing negative from positive biopsy: relationship to transitional zone volume","volume":"163","author":"Stamey","year":"2000","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.pop.2010.05.001_bib60","first-page":"1787","article-title":"Complexed prostate specific antigen improves the specificity for prostate cancer detection: results of a prospective multicenter clinical trial","volume":"170","author":"Partin","year":"2003","journal-title":"J\u00a0Urol"},{"issue":"4 Suppl 1","key":"10.1016\/j.pop.2010.05.001_bib61","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0090-4295(02)01693-X","article-title":"Complexed prostate-specific antigen for early detection of prostate cancer in men with serum prostate-specific antigen levels of 2 to 4 nanograms per milliliter","volume":"60","author":"Horninger","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.pop.2010.05.001_bib62","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1093\/clinchem\/46.10.1610","article-title":"Production and characterization of novel anti-prostate specific antigen (PSA) monoclonal antibodies that do not detect the internally cleaved Lys145-Lys146 inactive PSA","volume":"46","author":"Nurmikko","year":"2000","journal-title":"Clin Chem"},{"key":"10.1016\/j.pop.2010.05.001_bib63","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1093\/clinchem\/47.8.1415","article-title":"Discrimination of prostate cancer from benign disease by plasma measurement of intact, free prostate specific antigen lacking an internal cleavage site at Lys145-Lys146","volume":"47","author":"Nurmikko","year":"2001","journal-title":"Clin Chem"},{"key":"10.1016\/j.pop.2010.05.001_bib64","first-page":"1917","article-title":"Discrimination of benign from malignant prostatic disease by selective measurements of single chain, intact free prostate specific antigen","volume":"168","author":"Steuber","year":"2002","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.pop.2010.05.001_bib65","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1373\/49.2.253","article-title":"Benign prostate specific antigen (BPSA) in serum is increased in benign prostate disease","volume":"49","author":"Linton","year":"2003","journal-title":"Clin Chem"},{"key":"10.1016\/j.pop.2010.05.001_bib66","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/1097-0045(20001101)45:3<271::AID-PROS11>3.0.CO;2-T","article-title":"Seminal plasma contains \u201cBPSA\u201d, a molecular form of prostate specific antigen that is associated with benign prostatic hyperplasia","volume":"45","author":"Mikolajczyk","year":"2000","journal-title":"Prostate"},{"key":"10.1016\/j.pop.2010.05.001_bib67","first-page":"756","article-title":"A\u00a0precursor form of prostate specific antigen is highly elevated in prostate cancer compared with benign transitional zone prostate tissue","volume":"60","author":"Mikolajczyk","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.pop.2010.05.001_bib68","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/S0090-4295(97)00449-4","article-title":"A\u00a0precursor form of PSA (pPSA) is a component of the free PSA in prostate cancer serum","volume":"50","author":"Mikolajczyk","year":"1997","journal-title":"Urology"},{"key":"10.1016\/j.pop.2010.05.001_bib69","first-page":"6958","article-title":"A\u00a0truncated precursor form of prostate specific antigen is a more specific serum marker of prostate cancer","volume":"61","author":"Mikolajczyk","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.pop.2010.05.001_bib70","first-page":"957","article-title":"Identification of precursor forms of free prostate specific antigen in serum of prostate cancer patients by immunosorption and spectrometry","volume":"61","author":"Peter","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.pop.2010.05.001_bib71","doi-asserted-by":"crossref","first-page":"86","DOI":"10.2302\/kjm.52.86","article-title":"Pro PSA: a more cancer specific form of prostate specific antigen for the early detection of prostate cancer","volume":"52","author":"Mikolaiczyk","year":"2003","journal-title":"Keio J Med"},{"key":"10.1016\/j.pop.2010.05.001_bib72","first-page":"261","article-title":"Proenzyme PSA for the early detection of prostate cancer in the 2.5\u20134.0 ng\/ml total PSA range: preliminary analysis","volume":"59","author":"Sokoll","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.pop.2010.05.001_bib73","first-page":"2181","article-title":"Serum pro prostate specific antigen improves cancer detection compared to free and complexed prostate specific antigen in men with prostate specific antigen 2.4\u20134 ng\/ml","volume":"170","author":"Catalona","year":"2003","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.pop.2010.05.001_bib74","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0090-4295(98)00466-X","article-title":"Influence of age and prostate specific antigen on the chance of curable prostate cancer among men with nonpalpable disease","volume":"53","author":"Carter","year":"1999","journal-title":"Urology"},{"key":"10.1016\/j.pop.2010.05.001_bib75","first-page":"1964","article-title":"Prostate cancer in men age 50 years or younger: a review of the Department of Defense Center for Prostate Disease Research multicenter prostate cancer database","volume":"164","author":"Smith","year":"2000","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.pop.2010.05.001_bib76","first-page":"816","article-title":"Prospective characterization of pathological features of prostatic carcinomas detected via serum prostate specific antigen based screening","volume":"155","author":"Humphrey","year":"1996","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.pop.2010.05.001_bib77","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.urology.2004.04.008","article-title":"Relating biopsy and clinical variables to radical prostatectomy findings: can insignificant and advanced prostate cancer be predicted in a screened population?","volume":"64","author":"Anast","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.pop.2010.05.001_bib78","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0090-4295(96)00083-0","article-title":"Improving survival for patients with prostate cancer diagnosed in the prostate specific antigen era","volume":"48","author":"Gilliland","year":"1996","journal-title":"Urology"},{"key":"10.1016\/j.pop.2010.05.001_bib79","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1002\/1097-0142(20011115)92:10<2673::AID-CNCR1621>3.0.CO;2-2","article-title":"Improvements in pathologic staging for African American men undergoing radical retropubic prostatectomy during the prostate specific antigen era: implications for screening a high-risk group for prostate carcinoma","volume":"92","author":"Paquette","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.pop.2010.05.001_bib80","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1001\/jama.274.8.626","article-title":"Long term survival among men with conservatively treated localized prostate cancer","volume":"274","author":"Albertson","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.pop.2010.05.001_bib81","first-page":"4","article-title":"Commentary; annual screening for prostate cancer did not reduce mortality from prostate cancer","volume":"150","author":"Canfield","year":"2009","journal-title":"Evidence Based Med"},{"key":"10.1016\/j.pop.2010.05.001_bib82","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0090-4295(01)01264-X","article-title":"Prostate cancer mortality after introduction of prostate specific antigen mass screening in the federal state of Tyrol, Austria","volume":"58","author":"Bartsch","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.pop.2010.05.001_bib83","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1056\/NEJMoa0810084","article-title":"Screening and prostate-cancer mortality in a randomized European study","volume":"360","author":"Schr\u00f6der","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pop.2010.05.001_bib84","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1056\/NEJMoa0810696","article-title":"Mortality results from a randomized prostate-cancer screening trial","volume":"360","author":"Andriole","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pop.2010.05.001_bib85","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1370\/afm.942","article-title":"Cumulative incidence of false-positive results in repeated, multimodal cancer screening","volume":"7","author":"Croswell","year":"2009","journal-title":"Ann Fam Med"},{"key":"10.1016\/j.pop.2010.05.001_bib86","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1093\/jnci\/95.12.868","article-title":"Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer","volume":"95","author":"Draisma","year":"2003","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.pop.2010.05.001_bib87","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.amjmed.2004.06.036","article-title":"Psychological effects of a suspicious prostate cancer screening test followed by a benign biopsy result","volume":"117","author":"McNaughton-Collins","year":"2004","journal-title":"Am J Med"},{"key":"10.1016\/j.pop.2010.05.001_bib88","first-page":"129","article-title":"Prospective longitudinal comparative study of health-related quality of life in patients with radical prostatectomy or permanent brachytherapy for prostate cancer","volume":"63","author":"Kobuke","year":"2009","journal-title":"Acta Med Okayama"},{"key":"10.1016\/j.pop.2010.05.001_bib89","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1172\/JCI31399","article-title":"Improved prediction of prostate cancer recurrence through systems pathology","volume":"117","author":"Cordon-Cardo","year":"2007","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.pop.2010.05.001_bib90","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3322\/canjclin.51.1.38","article-title":"American cancer society guidelines for early detection of cancer: Update of early detection guidelines for prostate, colorectal and endometrial cancers","volume":"51","author":"Smith","year":"2001","journal-title":"CA Cancer J Clin"}],"container-title":["Primary Care: Clinics in Office Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095454310000527?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095454310000527?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T07:05:03Z","timestamp":1591772703000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0095454310000527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":90,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S0095454310000527"],"URL":"https:\/\/doi.org\/10.1016\/j.pop.2010.05.001","relation":{},"ISSN":["0095-4543"],"issn-type":[{"value":"0095-4543","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}